Zionsville, IN, United States of America

John M Schaus


Average Co-Inventor Count = 2.8

ph-index = 15

Forward Citations = 757(Granted Patents)

Forward Citations (Not Self Cited) = 680(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Zionsville, IN (US) (1992 - 2013)
  • Indianapolis, IN (US) (1984 - 2015)

Company Filing History:


Years Active: 1984-2015

Loading Chart...
Areas of Expertise:
CB-1 Ligands
Diacylglycerol Acyltransferase Inhibitors
5-HT7 Receptor Antagonists
Dopamine Receptor Antagonists
Serotonin Agonists
Histamine H3 Receptor Antagonists
Indole Derivatives
Aminotetralins
Piperazine Compounds
Heterocyclic Compounds
Migraine Treatments
Psychotic Disorder Treatments
101 patents (USPTO):Explore Patents

Title: The Inventor Extraordinaire: John M Schaus

Introduction:

John M Schaus, a brilliant inventor hailing from Zionsville, IN (US), is a pioneering figure in the field of pharmaceutical innovations. With an impressive portfolio of 101 patents to his name, Schaus continues to make significant strides in the realm of medical advancements.

Latest Patents:

Among his latest patents is the groundbreaking invention of 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, designed to address cognitive impairment associated with Parkinson's disease or schizophrenia. Additionally, Schaus has developed 1,5-Diphenyl-pyrrolidin-2-one compounds as CB-1 ligands, serving as CB-1 receptor inverse agonist compounds for the treatment of obesity or cognitive impairment linked to schizophrenia.

Career Highlights:

Schaus has made substantial contributions while working at Eli Lilly and Company, where his innovative spirit and dedication have led to significant breakthroughs in the pharmaceutical industry. His tenure at Eli Lilly Company has been marked by a commitment to excellence and a relentless pursuit of innovative solutions.

Collaborations:

Throughout his career, Schaus has collaborated with esteemed professionals such as Charles J Paget, Jr and Richard N Booher. These collaborations have not only enriched his work but have also paved the way for transformative inventions that promise to impact the field of medicine significantly.

Conclusion:

In conclusion, John M Schaus stands as a beacon of innovation, with a remarkable track record of pioneering inventions in the pharmaceutical sector. His unwavering passion for advancing medical science and improving patient outcomes underscores his status as a true visionary in the world of inventions and patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…